fda statement bpc 157 Healing Ankle Injuries: PRP vs BPC-157 & Regenerative Medicine FDA to weigh easing limits

This combination requires careful timing and may benefit from professional guidance

Product Specifications Compound: AOD-9604 Class: Synthetic peptide fragment / growth hormone C-terminal analog Origin: C-terminal fragment of human growth hormone (residues 177-191) with N-terminal tyrosine addition Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Molecular Weight: ~1815 Da Form: Lyophilized powder Vial Size: 5mg in 3mL glass vial Purity: 99%+ verified by HPLC and mass spectrometry (See COAs) Research Context AOD-9604 is utilized in research applications involving peptide chemistry , growth hormone fragment research , and cellular research applications

1987 Apr;48(4):1252-7

Gradual dose escalation assists in identifying the minimum effective dose and reduces the risk of sudden adverse tissue reactions

The biotech firm has two such analogs, a peptide and a small molecule, in preclinical development